• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
No Signs of the DOJ Letting Off the Pedal with Medicare Fraud Investigations

No Signs of the DOJ Letting Off the Pedal with Medicare Fraud Investigations

by Scott Wallask | May 15, 2025 | DOJ-lca, DOJ-nir, Enforcement-lca, Enforcement-lir, Essential, Lab Industry Advisor

However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Audits, the False Claims Act and Clinical Lab Enforcement: 2025 Trends and Compliance Tips

Audits, the False Claims Act and Clinical Lab Enforcement: 2025 Trends and Compliance Tips

by G2 Intelligence Staff | May 6, 2025 | OLP-Regular, Webinars

June 11th, 1:00pm ET Significant cases decided in 2024 and 2025 are shaping the landscape of enforcement for clinical laboratories. Government regulators continue to focus on medical necessity and improper business relationships, but they have expanded their focus to...
Labs in Court: Alleged Stark Law Violations Lead to $10m Settlement with DOJ

Labs in Court: Alleged Stark Law Violations Lead to $10m Settlement with DOJ

by Danielle Sloane, Morgan Tandy | Mar 19, 2025 | Lab Industry Advisor, Labs in Court-nir

Other recent legal actions include a self-disclosure settlement and punishment for alleged improper diagnostic test add-ons

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
September 2024 Labs in Court

September 2024 Labs in Court

by Danielle H. Tangorre, Seth B. Orkand | Aug 30, 2024 | Essential, Lab Industry Advisor, Labs in Court

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Special Report: The 2024 Lab Enforcement Landscape

Special Report: The 2024 Lab Enforcement Landscape

by Scott Wallask | Aug 29, 2024 | Enforcement-lca, Lab Industry Advisor, Premium

Lab leaders should be wary of telemedicine arrangements, certain marketing firms, and unnecessary PGx and CGx testing

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com